Privia Health: Athena Integration & Payer Rate Negotiations
Former VP of Growth at Privia Health
inpractise.com/articles/privia-health-and-us-physician-enablement-local-market-adaptation-advantage
Privia Health: Athena Integration & Payer Rate Negotiations(July 22, 2024)
Former VP of Growth at Privia Health
Interview Transcript
This is a snippet of the transcript, sign up to read more.
I have a lot of detailed questions, but maybe I'll just open it up to you. Privia has obviously had a lot of success. It came from essentially nowhere twelve years ago to being a pretty meaningfully sized company. As you think about the business over the next five to 10 years, what do you see as its opportunities, challenges, and relevance? Where are we in 10 years if we fast-forward this conversation?
I firmly believe that purely independent primary care will be extinct in five years. This means you won't find a physician in any market who isn't affiliated or contracted with some organization. It will become unsustainable for small practices, those with one to five doctors, to operate independently because they can't negotiate fee-for-service contracts effectively. No payer is going to increase their fee-for-service rates; they're only going to pay differently, which is through value-based care.
This is a snippet of the transcript, sign up to read more.
Related Content
UnitedHealth: Partner Healthcare Providers' VBC Migration Challenges
Former VP Value Based Care & Network Strategy at UnitedHealthcare
UnitedHealth, Elevance, Cigna & Value-Based Care: Acquiring vs Partnerships with Healthcare Providers
Former VP - New Ventures - Value-Based Care at UnitedHealth Group
US Value-Based Healthcare: Physician Incentives
Former VP of Corporate Venture Capital at Anthem
Elevance Health, UnitedHealth, Aetna & the US VBC Market: Payor-Provider Dynamics
Former National Vice President of Care Transformation at Elevance Health
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.